Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals, Inc. (TERN) Shares Outstanding (Diluted Average) (2021 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Shares Outstanding (Diluted Average) for 3 consecutive years, with $71.5 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Shares Outstanding (Diluted Average) rose 140.49% year-over-year to $71.5 million, compared with a TTM value of $71.5 million through Sep 2023, up 140.49%, and an annual FY2022 reading of $36.0 million, up 58.69% over the prior year.
  • Shares Outstanding (Diluted Average) was $71.5 million for Q3 2023 at Terns Pharmaceuticals, up from $70.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $71.5 million in Q3 2023 and bottomed at $21.8 million in Q3 2021.
  • Average Shares Outstanding (Diluted Average) over 3 years is $41.4 million, with a median of $29.7 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Diluted Average) soared 36.17% in 2022, then soared 178.91% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $22.7 million in 2021, then soared by 58.69% to $36.0 million in 2022, then soared by 98.51% to $71.5 million in 2023.
  • Business Quant data shows Shares Outstanding (Diluted Average) for TERN at $71.5 million in Q3 2023, $70.6 million in Q2 2023, and $69.8 million in Q1 2023.